Journal of Autoimmunity

Papers
(The TQCC of Journal of Autoimmunity is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Janus kinase inhibition prevents autoimmune diabetes in LEW.1WR1 rats441
Safety of biologic immunosuppressants in pregnant women with immune-mediated inflammatory diseases175
Advances in SLE classification criteria159
Striatin-3 is a human autoantigen but it is not associated with the S-phase G2 nuclear antigen (SG2NA) staining pattern151
HNF4α, SP1 and c-myc are master regulators of CNS autoimmunity125
ATP-binding cassette G1 membrane transporter-mediated cholesterol efflux capacity influences coronary atherosclerosis and cardiovascular risk in Rheumatoid Arthritis121
GILZ regulates type I interferon release and sequesters STAT1119
The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trial117
Immunological and fibrotic profiling in the NOD.c3c4 murine model of autoimmune cholangitis106
Ectopic CD4+ T cells in choroid plexus mediate neuropsychiatric lupus symptoms in mice via interferon-γ induced microglia activation106
Autoimmune associated HLAs and T cell autoantigens exhibit common patterns across several autoimmune diseases100
Autoreactivity to self-antigens LL37 and ADAMTSL5 influences the clinical response to risankizumab in psoriatic patients85
Differences in innate immune cell populations distinguish autoimmune from herpesvirus-associated encephalitis85
Breach of tolerance versus burden of bile acids: Resolving the conundrum in the immunopathogenesis and natural history of primary biliary cholangitis83
Editorial Board64
Tfh cell-derived small extracellular vesicles exacerbate the severity of collagen-induced arthritis by enhancing B-cell responses63
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations61
PAD2-mediated citrullination of MBP and early myelin destabilization in multiple sclerosis61
Lupus nephritis: new progress in diagnosis and treatment60
Global and regional epidemiology of psoriatic arthritis in patients with psoriasis: A comprehensive systematic analysis and modelling study60
Anti-annexin A4 antibody as a biomarker for desquamative interstitial pneumonia59
Editorial Board59
Editorial Board58
LAT1 enables T cell activation under inflammatory conditions57
Post-translationally modified proteins bind and activate complement with implications for cellular uptake and autoantibody formation52
Targeting macrophages with phosphatidylserine-rich liposomes as a potential antigen-specific immunotherapy for type 1 diabetes52
Sunscreen use associated with elevated prevalence of anti-nuclear antibodies in U.S. adults48
Editorial Board46
Free water in the hippocampal cingulum as a Radiomic biomarker for Identifying inflammatory neuropsychiatric Lupus: A cross-sectional case-control study46
Identification of the central tolerance checkpoint for autoreactive proteinase 3+ B cells in human bone marrow45
Deciphering Sjögren's disease: New insights and perspectives extend from advanced omics approaches and immunology43
Mitochondrial dysfunction is a potential key mechanism for atherosclerosis predisposition in patients with systemic lupus erythematosus42
Earlier vs. later time period of COVID-19 infection and emergent autoimmune signs, symptoms, and serologies41
FAPI PET/CT for tracking disease trajectory in myositis-related interstitial lung disease41
Autoantibodies against a subunit of mitochondrial respiratory chain complex I in inclusion body myositis40
Proinflammatory CD20+CD3+ T cells as a potential driver of macrophage reprogramming in rheumatoid arthritis38
Whole blood transcriptome identifies interferon-regulated genes as key drivers in thrombotic primary antiphospholipid syndrome38
Cellular communication network factor 3 contributes to the pathological process of rheumatoid arthritis through promoting cell senescence and osteoclastogenesis in the joint38
The complement system and human autoimmune diseases38
Glycobiology of psoriasis: A review36
Assessment of the 2023 ACR/EULAR antiphospholipid syndrome classification criteria in a Chinese cohort: Impact on clinical practice36
Interferon signatures fuel B cell hyperactivity and plasmablast expansion in systemic lupus erythematosus35
Non-coding RNAs in immunoregulation and autoimmunity: Technological advances and critical limitations34
Antigenic mimicry – The key to autoimmunity in immune privileged organs32
External and internal exposome as triggers of biological signalling in systemic sclerosis – A narrative synthesis32
Editorial Board32
Perinatal use of targeted synthetic DMARDs and maternal-neonatal outcomes in autoimmune disease: A population-based cohort study31
Antigen-specific immune reactions by expanded CD8+ T cell clones from HLA-B*27-positive patients with spondyloarthritis31
Renal and vascular outcomes in patients with isolated antiphospholipid syndrome nephropathy31
Single-cell sequencing of the retina shows that LDHA regulates pathogenesis of autoimmune uveitis30
Autoimmune markers and vascular immune deposits in Finkelstein-Seidlmayer vasculitis: Systematic literature review30
Editorial Board30
Impact of BNT162b2 mRNA anti-SARS-CoV-2 vaccine on interferon-alpha production by plasmacytoid dendritic cells and autoreactive T cells in patients with systemic lupus erythematosus: The COVALUS proje30
The aryl hydrocarbon receptor in immune regulation and autoimmune pathogenesis28
Autoantibodies in systemic lupus erythematosus: From immunopathology to therapeutic target27
Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus27
Clinical targeted treatment in Sjogren's disease: A systematic literature review for an evidence-based medicine approach27
Differential changes in the gut microbiota between extrinsic and intrinsic atopic dermatitis26
Peripheral immune profiling highlights a dynamic role of low-density granulocytes in myasthenia gravis26
Clinical utility of measuring CD4+ T follicular cells in patients with immune dysregulation26
Long-term efficacy and safety of colchicine and anti-IL-1 blockers in FMF: results from the Eurofever multicenter observational study26
Modulation of PKM2 inhibits follicular helper T cell differentiation and ameliorates inflammation in lupus-prone mice26
Pregnancy-related complications in systemic lupus erythematosus25
LAMP3-mediated epithelial-mesenchymal transition promotes the invasion and excessive proliferation of fibroblast-like synoviocytes in rheumatoid arthritis25
The role of gut flora-driven Th cell responses in preclinical rheumatoid arthritis25
Familial patterns of alopecia areata: A systematic review and meta-analysis25
Silencing of aryl hydrocarbon receptor repressor restrains Th17 cell immunity in autoimmune hepatitis25
Coronavirus disease 2019, vaccination against coronavirus and immunoglobulin A-mediated diseases: systematic literature review25
Environmental exposures as risk factors for idiopathic inflammatory myopathies24
Altered lipid metabolism in synovial fibroblasts of individuals at risk of developing rheumatoid arthritis24
Alternate splicing converts human CD137 from costimulatory to immunosuppressive function24
Does COVID-19 impact the prevalence of myositis specific antibodies in the Netherlands? A comparative nationwide study24
Temporal trajectories and DMARD therapy retention of rheumatoid arthritis patients with different autoimmune and inflammatory comorbidity profiles: a retrospective analysis24
Autoantibodies against α-synuclein inhibit its aggregation and cytotoxicity24
T cell aging as a risk factor for autoimmunity24
Identifying the genetic association between systemic lupus erythematosus and the risk of autoimmune liver diseases23
Evaluation of the mycophenolate mofetil–rituximab combination in systemic sclerosis: a French retrospective multicenter study (MycRiSSc)23
Functional metagenomic analysis reveals potential inflammatory triggers associated with genetic risk for autoimmune disease23
Editorial Board23
Interleukin 17-producing C-C motif chemokine receptor 6 + conventional CD4+ T cells are arthritogenic in an animal model of spondyloarthritis23
Recent advances in cutaneous lupus23
Acquired susceptibility to autoimmune diseases in pediatric patients with Escherichia coli infection: A population-matched retrospective cohort study22
Significance of anti-transcobalamin receptor antibodies in cutaneous arteritis revealed by proteome-wide autoantibody screening22
Pathophysiological effects of long COVID-19 (auto)antibodies on fertility22
Extracellular vesicle autoantibodies22
JAK inhibitors in refractory juvenile rheumatic diseases: Efficacy, tolerance and type-I interferon profiling, a single center retrospective study22
Preliminary safety and efficacy of relmacabtagene autoleucel (relma-cel) in adults with moderately to severely active systemic lupus erythematosus: a phase I dose-escalation study21
2023 International Consensus Guidance for the use of Tripterygium Wilfordii Hook F in the treatment of active rheumatoid arthritis21
Methotrexate and low-dose prednisone in idiopathic retroperitoneal fibrosis: a randomised clinical trial21
Interleukin-15 is a hair follicle immune privilege guardian21
High-content multimodal analysis supports the IL-7/IL-7 receptor axis as a relevant therapeutic target in primary Sjögren's syndrome21
Pro-fibrotic effect of the susceptible gene PCSK5 in vascular fibrosis of Takayasu arteritis via TGF-β and SMAD3 signaling pathway activation21
Suppression of YTHDF2 attenuates autoimmune hepatitis by expansion of myeloid-derived suppressor cells20
T follicular helper cells in autoimmune diseases20
Pin1 maintains the effector program of pathogenic Th17 cells in autoimmune neuroinflammation20
A survey of ficolin-3 activity in Systemic Lupus Erythematosus reveals a link to hematological disease manifestations and autoantibody profile20
Gut microbiota in systemic lupus erythematosus: A fuse and a solution20
Altered glucose metabolism in B cells: Implications for the pathogenesis and treatment of autoimmune diseases20
Application of laboratory models for sarcoidosis research20
Anti-DNA antibody-targeted D-peptide nanoparticles ameliorate lupus nephritis in MRL/lpr mice20
Fecal microbiota transplantation in the treatment of systemic lupus erythematosus: What we learnt from the explorative clinical trial19
Association between age groups and relapse of type 1 autoimmune pancreatitis: a large-scale retrospective cohort study19
Genetic and pharmacological targeting of GSDMD ameliorates systemic inflammation in macrophage activation syndrome19
Physical work demands and risk of rheumatoid arthritis, systemic sclerosis, and systemic lupus erythematosus. A Danish longitudinal cohort study19
Natural IgG protects against early dissemination of vesicular stomatitis virus19
Neutrophil activation biomarker pentraxin 3 for diagnosis and monitoring of macrophage activation syndrome occurrence in adult-onset Still's disease18
Editorial Board18
Immunosuppression induces regression of fibrosis in primary biliary cholangitis with moderate-to-severe interface hepatitis18
VEXAS syndrome: A newly identified X-Linked hematoinflammatory disorder – A comprehensive overview of its genetic, molecular, inflammatory, and clinical landscape18
Regulatory T cells effectively downregulate the autoimmune anti-MPO response and ameliorate anti-MPO induced glomerulonephritis in mice18
Acute-type acquired hemophilia A after COVID-19 mRNA vaccine administration: A new disease entity?18
Multi-omics study reveals different pathogenesis of the generation of skin lesions in SLE and IDLE patients18
Autoimmune diseases and the risk of bladder cancer: A Mendelian randomization analysis18
CD72-semaphorin3A axis: A new regulatory pathway in systemic lupus erythematosus18
Comprehensive description of adult-onset Still's disease after COVID-19 vaccination18
Developmental drugs for sarcoidosis17
PD1+ innate lymphoid cells 3 predict JAK-dependent inflammation in rheumatoid arthritis17
Vascular effects of achieving low disease activity in axial spondyloarthritis – A 2-year prospective treat-to-target study17
Treatment of mixed connective tissue disease: A multicenter retrospective study17
Amelioration of immunoglobulin A vasculitis by suppression of the pathological expansion of T follicular helper 17 cells17
Cognitive dysfunction in SLE: An understudied clinical manifestation17
Accelerated waning of immune responses to a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases17
Poorer survival for patients with inflammatory arthritis treated with immune checkpoint inhibitors for melanoma17
Chimeric antigen receptor T cell therapy: a new frontier therapeutic landscape in autoimmune diseases16
Elevated unphosphorylated STAT1 and IRF9 in T and B cells of primary sjögren's syndrome: Novel biomarkers for disease activity and subsets16
Extracellular microRNAs induce dendritic cell-dependent joint inflammation and potentiate osteoclast differentiation via TLR7/8 engagement16
PD-1 antibody interactions with Fc gamma receptors enable PD-1 agonism to inhibit T cell activation – therapeutic implications for autoimmunity16
Repeated immunization with ATRA-containing liposomal adjuvant transdifferentiates Th17 cells to a Tr1-like phenotype16
Cytokine producing B-cells and their capability to polarize macrophages in giant cell arteritis16
Monoclonal antibodies from B cells of patients with anti-MDA5 antibody-positive dermatomyositis directly stimulate interferon gamma production16
Autoimmune hepatitis following COVID-19 vaccination15
Elderly-onset systemic sclerosis defines a distinct clinical subset: analysis from the SPRING registry of the Italian Society for Rheumatology15
The double-edged sword role of copper in rheumatoid arthritis: Mechanisms, therapeutics, and challenges15
Sonic hedgehog promotes synovial inflammation and articular damage through p38 mitogen-activated protein kinase signaling in experimental arthritis15
Comparative effectiveness of preventive treatment with dimethyl fumarate-loaded solid lipid nanoparticles and oral dimethyl fumarate in a mouse model of multiple sclerosis15
Diversity and function of regulatory T cells in health and autoimmune diseases15
Runx3 instructs Aire+ mTEC development, TSA gene expression, and central tolerance15
Outcome and prognosis of isolated carotid vasculitis15
Pathogenicity of functionally activated PD-1+CD8+ cells and counterattacks by muscular PD-L1 through IFNγ in myositis15
PPARG-mediated autophagy activation alleviates inflammation in rheumatoid arthritis15
Pre-existing conditions associated with post-acute sequelae of COVID-1915
A cluster of type II interferon-regulated genes associates with disease activity in patients with systemic lupus erythematosus15
Beyond screening for pulmonary arterial hypertension: The DETECT score is a potential promising prediction tool for all-cause mortality in systemic sclerosis: Analysis from the EUSTAR database15
Autophagy pathways in autoimmune diseases15
0.20888113975525